Published in Proc Natl Acad Sci U S A on October 01, 1975
Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci U S A (1976) 3.15
Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J (1996) 2.89
Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J (1985) 2.55
New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. J Clin Invest (1980) 2.48
The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement. Biochem J (1977) 1.78
Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. Proc Natl Acad Sci U S A (1980) 1.73
Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. J Clin Invest (1983) 1.69
Primary structure of the gamma-carboxyglutamic acid-containing protein from bovine bone. Proc Natl Acad Sci U S A (1976) 1.58
Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol (1983) 1.37
Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest (1995) 1.36
The role of osteocalcin in human glucose metabolism: marker or mediator? Nat Rev Endocrinol (2012) 1.31
Experimental vitamin K deficiency and spontaneous metastases. Br J Cancer (1977) 1.26
The presence of protein-bound gamma-carboxyglutamic acid in calcium-containing renal calculi. J Clin Invest (1977) 1.24
Excessive mineralization with growth plate closure in rats on chronic warfarin treatment. Proc Natl Acad Sci U S A (1982) 1.24
Vitamin K-dependent carboxylation of osteocalcin: friend or foe? Adv Nutr (2012) 1.22
Recruitment of osteoclast precursors by purified bone matrix constituents. J Cell Biol (1982) 1.18
Association of congenital deficiency of multiple vitamin K-dependent coagulation factors and the phenotype of the warfarin embryopathy: clues to the mechanism of teratogenicity of coumarin derivatives. Am J Hum Genet (1987) 1.08
Characterization of a tumor necrosis factor-responsive element which down-regulates the human osteocalcin gene. Mol Cell Biol (1993) 1.08
Bone turnover in early rheumatoid arthritis. 1. Biochemical and kinetic indexes. Ann Rheum Dis (1985) 1.07
Serum osteocalcin in rheumatoid arthritis and other inflammatory arthritides: relation between inflammatory activity and the effect of glucocorticoids and remission inducing drugs. Ann Rheum Dis (1986) 1.05
Gla-rich protein (GRP), a new vitamin K-dependent protein identified from sturgeon cartilage and highly conserved in vertebrates. J Biol Chem (2008) 1.00
Multiple immunoreactive forms of osteocalcin in uremic serum. J Clin Invest (1986) 0.99
The three-dimensional structure of bovine calcium ion-bound osteocalcin using 1H NMR spectroscopy. Biochemistry (2003) 0.98
The role of vitamin K in soft-tissue calcification. Adv Nutr (2012) 0.98
Serum osteocalcin or bone Gla-protein, a biochemical marker for bone metabolism in horses: differences in serum levels with age. Can J Vet Res (1990) 0.96
Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion. J Clin Invest (1985) 0.96
Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules. J Bone Miner Metab (2008) 0.95
Vitamin K-dependent calcium binding proteins in aortic valve calcification. J Clin Invest (1980) 0.95
Extraskeletal osteosarcoma with pulmonary metastasis in a female f344 rat. J Toxicol Pathol (2011) 0.95
Purification and characterization of an abnormal factor IX (Christmas factor) molecule. Factor IX Chapel Hill. J Clin Invest (1978) 0.94
Monoclonal antibodies to native noncollagenous bone-specific proteins. Proc Natl Acad Sci U S A (1984) 0.92
Circular dichroic, infrared and other studies on the protein component of pig brain thromboplastin. Biochem J (1980) 0.92
Bone as an endocrine organ. Endocr Pract (2012) 0.92
Age- and gender-related changes in the distribution of osteocalcin in the extracellular matrix of normal male and female bone. Possible involvement of osteocalcin in bone remodeling. J Clin Invest (1994) 0.91
The apparent absence of involvement of biotin in the vitamin K-dependent carboxylation of glutamic acid residues of proteins. Biochem J (1977) 0.86
Gamma-carboxyglutamate in normal and pathological human middle ear bones. Arch Otorhinolaryngol (1984) 0.83
Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry. J Clin Invest (1986) 0.82
An overview of the metabolic functions of osteocalcin. Rev Endocr Metab Disord (2015) 0.82
Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism. J Clin Invest (1988) 0.81
An overview of osteocalcin progress. J Bone Miner Metab (2016) 0.81
The biosynthesis of dentine gamma-carboxyglutamic acid-containing proteins by rat incisor odontoblasts in organ culture. Biochem J (1983) 0.80
Comparison of inhibitory effects of warfarin on gamma-carboxylation between bone and liver in rats. J Bone Miner Metab (2005) 0.79
X-ray crystal structure of bovine 3 Glu-osteocalcin. Biochemistry (2013) 0.78
1,25-Dihydroxyvitamin D stimulation test for osteoblast function in normal and osteoporotic postmenopausal women. J Clin Invest (1987) 0.78
Influence of bone osteocalcin levels on bone loss induced by ovariectomy in rats. J Bone Miner Metab (2007) 0.78
The role of α-zearalanol in reversing bone loss induced by ovarian hormone deficiency in rats. J Bone Miner Metab (2011) 0.77
Isolation and partial characterization of a vitamin K-dependent carboxylase from bovine aortae. Biochem J (1987) 0.77
The (1)H NMR structure of bovine Pb(2+)-osteocalcin and implications for lead toxicity. Biochim Biophys Acta (2008) 0.76
Metabolomics identifies the intersection of phosphoethanolamine with menaquinone-triggered apoptosis in an in vitro model of leukemia. Mol Biosyst (2015) 0.75
Osteosclerosis associated with urinary tract malignancy may not be dependent upon bone metastases. Trans Am Clin Climatol Assoc (1983) 0.75
Matrix Gla protein in tumoral pathology. Clujul Med (2016) 0.75
Taking cues from the extracellular matrix to design bone-mimetic regenerative scaffolds. Matrix Biol (2016) 0.75
Evidence for the vitamin K-dependent gamma-carboxylation of the first glutamic acid residue in peptide substrates containing a diglutamyl sequence. Biochem J (1983) 0.75
Characterization of a silencer element in the first exon of the human osteocalcin gene. Nucleic Acids Res (1995) 0.75
Vitamin K and hepatocellular carcinoma: The basic and clinic. World J Clin Cases (2015) 0.75
The role of amino acids in hydroxyapatite mineralization. J R Soc Interface (2016) 0.75
Development of a nonthrombogenic collagenous blood-prosthetic interface. Ann Surg (1980) 0.75
Unreported intrinsic disorder in proteins: Building connections to the literature on IDPs. Intrinsically Disord Proteins (2014) 0.75
Human peripheral monocytes express putative receptors for neuroexcitatory amino acids. Proc Natl Acad Sci U S A (1986) 0.75
Ultrastructural and biochemical aspects of matrix vesicle-mediated mineralization. Jpn Dent Sci Rev (2016) 0.75
Effects of starch concentration on calcium-enhanced black bullhead catfish protein gels. Food Sci Nutr (2017) 0.75
Multifaceted interaction of bone, muscle, lifestyle interventions and metabolic and cardiovascular disease: role of osteocalcin. Osteoporos Int (2017) 0.75
The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem (1969) 142.11
DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci (1964) 127.96
Isolation of a calcium-sequestering protein from sarcoplasmic reticulum. Proc Natl Acad Sci U S A (1971) 3.98
Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci U S A (1974) 3.24
The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin. J Biol Chem (1974) 2.59
Vitamin D-dependent calcium-binding protein. Purification and some properties. J Biol Chem (1968) 2.41
Agarose gel electrophoresis. Scand J Clin Lab Invest Suppl (1972) 2.32
Troponin and parvalbumin calcium binding regions predicted in myosin light chain and T4 lysozyme. Science (1975) 1.96
Primary structure of the vitamin K-dependent part of prothrombin. FEBS Lett (1974) 1.74
A new carboxylation reaction. The vitamin K-dependent incorporation of H-14-CO3- into prothrombin. J Biol Chem (1975) 1.71
The phosphoprotein of the dentin matrix. Biochemistry (1967) 1.62
Congenital malformations associated with the administration of oral anticoagulants during pregnancy. J Pediatr (1975) 1.52
Anticoagulant therapy with cardiac valve prosthesis during pregnancy. Obstet Gynecol (1973) 1.49
Some studies on the composition of bovine cortical-bone sialoprotein. Biochem J (1967) 1.29
The mode of action of vitamin K. Isolation of a peptide containing the vitamin K-dependent portion of prothrombin. Proc Natl Acad Sci U S A (1973) 1.26
Neutral sites for calcium ion binding to elastin and collagen: a charge neutralization theory for calcification and its relationship to atherosclerosis. Proc Natl Acad Sci U S A (1971) 1.24
Histochemistry and biochemistry of calcification with special reference to the role of lipids. Clin Orthop Relat Res (1968) 1.19
Vitamin K and the biosynthesis of prothrombin. 3. Structural comparison of an NH2-terminal fragment from normal and from dicoumarol-induced bovine prothrombin. J Biol Chem (1973) 1.19
Binding of Ca 2+ to normal and dicoumarol-induced prothrombin. Biochem Biophys Res Commun (1973) 1.11
The amino acid sequence of two O-phosphoserine containing tripeptides isolated from the organic matrix of embryonic bovine enamel. Biochim Biophys Acta (1969) 1.03
The isolation of an EDTA-soluble phosphoprotein from mineralizing bovine dentin. Biochim Biophys Acta (1972) 1.01
Vitamin K and the biosynthesis of prothrombin. II. Structural comparison of normal and dicoumarol-induced bovine prothrombin. J Biol Chem (1972) 1.01
Dentin matrix collagen: evidence for a covalently linked phosphoprotein attachment. Calcif Tissue Res (1971) 1.01
[3H]diborane reduction of vitamin K-dependent calcium-binding proteins. Identification of a unique amino acid. J Biol Chem (1975) 0.95
The localization of a vitamin K-induced modification in an N-terminal fragment of human prothrombin. Biochem J (1974) 0.90
Properties of a Ca2+ binding peptide from prothrombin. Biochem Biophys Res Commun (1974) 0.89
A comparison of histological methods for demonstrating calcification. Calcif Tissue Res (1973) 0.87
The role of carboxyl groups in collagen calcification. Biochem Biophys Res Commun (1972) 0.83
Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol (1990) 4.27
The glycosylation of hemoglobin: relevance to diabetes mellitus. Science (1978) 3.87
Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev (1989) 3.87
Cross-linking in collagen and elastin. Annu Rev Biochem (1984) 3.51
The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo. J Clin Invest (1976) 3.00
Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J (1996) 2.89
Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus. J Clin Endocrinol Metab (1977) 2.84
Structure of hemoglobin AIc: nature of the N-terminal beta chain blocking group. Biochem Biophys Res Commun (1968) 2.60
Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J (1990) 2.55
Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev (1993) 2.52
Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc Natl Acad Sci U S A (2001) 2.52
Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. J Biol Chem (1986) 2.50
Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c. Biochem Biophys Res Commun (1975) 2.46
Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem (1997) 2.27
Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription. J Cell Sci (2000) 2.08
Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Proc Natl Acad Sci U S A (1997) 2.06
Transcriptional control of osteoblast growth and differentiation. Physiol Rev (1996) 2.06
Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev (2006) 2.04
Specific detection of quinoproteins by redox-cycling staining. J Biol Chem (1991) 1.97
Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene (2009) 1.87
Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J Cell Physiol (2000) 1.76
A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J Cell Sci (2001) 1.74
Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D-responsive transcription and contribute to chromatin organization. Mol Cell Biol (1999) 1.72
Posttranslational protein modifications, with special attention to collagen and elastin. Physiol Rev (1975) 1.69
Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J Clin Invest (1999) 1.62
Osteocalcin: isolation, characterization, and detection. Methods Enzymol (1984) 1.62
Stage-specific expression of Dlx-5 during osteoblast differentiation: involvement in regulation of osteocalcin gene expression. Mol Endocrinol (1997) 1.61
runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins. Mol Cell Biol (2001) 1.59
Ultrastructural immunolocalization of noncollagenous (osteopontin and osteocalcin) and plasma (albumin and alpha 2HS-glycoprotein) proteins in rat bone. J Bone Miner Res (1993) 1.58
Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem (1999) 1.54
Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy. Proc Natl Acad Sci U S A (1999) 1.53
Intranuclear targeting of AML/CBFalpha regulatory factors to nuclear matrix-associated transcriptional domains. Proc Natl Acad Sci U S A (1998) 1.52
Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice. J Exp Med (1999) 1.51
An NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol (1995) 1.51
Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev Biol (1987) 1.51
Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol (1990) 1.50
The nuclear matrix protein NMP-1 is the transcription factor YY1. Proc Natl Acad Sci U S A (1995) 1.49
Calcium-dependent alpha-helical structure in osteocalcin. Biochemistry (1982) 1.47
Osteocalcin gene promoter-binding factors are tissue-specific nuclear matrix components. Proc Natl Acad Sci U S A (1993) 1.46
Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res (1996) 1.45
PQQ, the elusive coenzyme. Trends Biochem Sci (1989) 1.42
Analysis of nucleotide pools in animal cells. Methods Cell Biol (1973) 1.41
Quantitative determination of gamma-carboxyglutamic acid in proteins. Anal Biochem (1977) 1.40
Modification and introduction of a specific radioactive label into the erythrocyte membrane sialoglycoproteins. Biochem Biophys Res Commun (1972) 1.39
The presence of gamma-carboxyglutamic acid in the proteins associated with ectopic calcification. Biochem Biophys Res Commun (1976) 1.38
Replication-dependent histone gene expression is related to Cajal body (CB) association but does not require sustained CB contact. Mol Biol Cell (2001) 1.38
Tumor cells exhibit deregulation of the cell cycle histone gene promoter factor HiNF-D. Science (1990) 1.37
Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology (2001) 1.34
Structure and metabolism of connective 801 tissue proteins. Annu Rev Biochem (1972) 1.34
Nuclear matrix association of multiple sequence-specific DNA binding activities related to SP-1, ATF, CCAAT, C/EBP, OCT-1, and AP-1. Biochemistry (1993) 1.33
Carboxylated calcium-binding proteins and vitamin K. N Engl J Med (1980) 1.31
Structural heterogeneity of human hemoglobin A due to nonenzymatic glycosylation. J Biol Chem (1979) 1.30
Vitamin D-mediated modifications in protein-DNA interactions at two promoter elements of the osteocalcin gene. Proc Natl Acad Sci U S A (1990) 1.30
Structure of a new pyrimidine from Bacillus subtilis phage SP-15 nucleic acid. Nat New Biol (1972) 1.30
The nature of crosslinking in collagens from mineralized tissues. Biochem Biophys Res Commun (1971) 1.29
Modification of sialyl residues of sialoglycoprotein(s) of the human erythrocyte surface. J Biol Chem (1973) 1.28
Human H4 histone gene transcription requires the proliferation-specific nuclear factor HiNF-D. Auxiliary roles for HiNF-C (Sp1-like) and HiNF-A (high mobility group-like). J Biol Chem (1989) 1.28
Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation. Endocrinology (1996) 1.28
Apoptosis during bone-like tissue development in vitro. J Cell Biochem (1998) 1.25
The presence of protein-bound gamma-carboxyglutamic acid in calcium-containing renal calculi. J Clin Invest (1977) 1.24
The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFalpha2 transcription factor. Proc Natl Acad Sci U S A (1999) 1.24
Crystal structure of the nuclear matrix targeting signal of the transcription factor acute myelogenous leukemia-1/polyoma enhancer-binding protein 2alphaB/core binding factor alpha2. J Biol Chem (1999) 1.22
An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc Natl Acad Sci U S A (1996) 1.21
Transcriptional control of the tissue-specific, developmentally regulated osteocalcin gene requires a binding motif for the Msx family of homeodomain proteins. Proc Natl Acad Sci U S A (1994) 1.20
Binding of calcium to SP-A, a surfactant-associated protein. Biochemistry (1990) 1.19
Targeting of the YY1 transcription factor to the nucleolus and the nuclear matrix in situ: the C-terminus is a principal determinant for nuclear trafficking. J Cell Biochem (1998) 1.19
TGF beta alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype. J Cell Physiol (1994) 1.17
Sequence-specific DNA-binding proteins are components of a nuclear matrix-attachment site. Proc Natl Acad Sci U S A (1992) 1.16
The cell cycle regulator p27kip1 contributes to growth and differentiation of osteoblasts. Cancer Res (1999) 1.13
Sequence analysis of microgram amounts of peptides by mass spectrometry. Anal Biochem (1970) 1.12
Atherocalcin, a gamma-carboxyglutamic acid containing protein from atherosclerotic plaque. Biochem Biophys Res Commun (1979) 1.12
Overlapping and CpG methylation-sensitive protein-DNA interactions at the histone H4 transcriptional cell cycle domain: distinctions between two human H4 gene promoters. Mol Cell Biol (1992) 1.12
Expression of cell growth and bone specific genes at single cell resolution during development of bone tissue-like organization in primary osteoblast cultures. J Cell Biochem (1992) 1.11
Structure of two histidine-containing crosslinks from collagen. J Biol Chem (1973) 1.11
Progressive changes in the protein composition of the nuclear matrix during rat osteoblast differentiation. Proc Natl Acad Sci U S A (1990) 1.11
Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J Cell Biochem (2001) 1.10
Effects of interleukin-1 beta and tumor necrosis factor-alpha on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitro. Inflammation (1992) 1.10
Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes. J Cell Biochem (1992) 1.10
Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Mol Endocrinol (1996) 1.09
Collagen crosslinks: isolation of reduced N -hexosylhydroxylysine from borohydride-reduced calf skin insoluble collagen. Arch Biochem Biophys (1972) 1.09
Association of congenital deficiency of multiple vitamin K-dependent coagulation factors and the phenotype of the warfarin embryopathy: clues to the mechanism of teratogenicity of coumarin derivatives. Am J Hum Genet (1987) 1.08
Intranuclear trafficking of transcription factors: implications for biological control. J Cell Sci (2000) 1.08
Nuclear structure-gene expression interrelationships: implications for aberrant gene expression in cancer. Cancer Res (2000) 1.08
Presence of osteocalcin and related higher molecular weight 4-carboxyglutamic acid-containing proteins in developing bone. J Biol Chem (1983) 1.07
Alpha-amino alcohols as products of a reductive side reaction of denatured collagen with sodium borohydride. Biochemistry (1970) 1.07
Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria. J Cell Biol (1993) 1.06
Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-deplete bone implants. Cell Differ (1987) 1.05
Modifications of protein-DNA interactions in the proximal promoter of a cell-growth-regulated histone gene during onset and progression of osteoblast differentiation. Proc Natl Acad Sci U S A (1990) 1.05
Regulation of histone gene expression. Curr Opin Cell Biol (1992) 1.05
Collagen crosslinking: isolation of hydroxyaldol-histidine, a naturally-occurring crosslink. Biochem Biophys Res Commun (1975) 1.05
Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. J Clin Endocrinol Metab (1984) 1.03
Interleukin-1 beta stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res (1991) 1.02